- £33.37m
- £35.64m
- £14.12m
- 67
- 19
- 97
- 67
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15.7 | 16.3 | 8.37 | 13.2 | 14.1 |
Cost of Revenue | |||||
Gross Profit | 10.7 | 11.1 | 5.06 | 8.56 | 9.38 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 12.9 | 13.8 | 11.1 | 13.3 | 13.5 |
Operating Profit | 2.75 | 2.52 | -2.77 | -0.036 | 0.658 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2.66 | 2.4 | -2.82 | -0.174 | 0.452 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.48 | 2.43 | -1.96 | 0.187 | 0.161 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.48 | 2.43 | -1.96 | 0.187 | 0.161 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.48 | 2.43 | -1.96 | 0.187 | 0.161 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.081 | 0.085 | -0.081 | 0.011 | 0.009 |
Dividends per Share |